Type 1 Diabetes Trial, Recruiting (NCT07150052)

Type 1 Diabetes Trial, Recruiting NCT07150052 Sponsor: University of Sao Paulo Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT07150052 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with type 1 diabetes mellitus
Children aged 6 to 18 years old (along with their caregivers), or adults over 18 years old
People whose HbA1c blood sugar level (a measure of average blood sugar over recent months) was between 7.2% and 10.5% in the last 6 months
People who are on a "basal-bolus" insulin routine (a type of insulin plan involving both long-acting and short-acting insulin doses)
People who have taken part in guidance on how to use the program being tested in this study
People who agree to and sign the informed consent form
People who attend regular check-up visits at the diabetes outpatient clinic at HC-FMUSP

Who may not be able to join:

People who are unable to understand the study instructions
People who are unable to read or write
People who do not attend the required study visits
People who do not use the study tool through WhatsApp
People who do not agree to the consent form
People who use the study tool fewer than 3 days per week during the study period

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +5511981467909

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07150052

Sponsor: University of Sao Paulo

Phase: Not Applicable

Status: Recruiting

Condition: Type 1 Diabetes

Trial contact: +5511981467909

More information: https://clinicaltrials.gov/study/NCT07150052

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with type 1 diabetes mellitus
Children aged 6 to 18 years old (along with their caregivers), or adults over 18 years old
People whose HbA1c blood sugar level (a measure of average blood sugar over recent months) was between 7.2% and 10.5% in the last 6 months
People who are on a "basal-bolus" insulin routine (a type of insulin plan involving both long-acting and short-acting insulin doses)
People who have taken part in guidance on how to use the program being tested in this study
People who agree to and sign the informed consent form
People who attend regular check-up visits at the diabetes outpatient clinic at HC-FMUSP

Who may not be able to join:

People who are unable to understand the study instructions
People who are unable to read or write
People who do not attend the required study visits
People who do not use the study tool through WhatsApp
People who do not agree to the consent form
People who use the study tool fewer than 3 days per week during the study period

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Sao Paulo

Registry

ClinicalTrials.gov

Start date

1 May 2025

Est. completion

1 October 2025

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Glycated hemoglobin (HbA1c); - time in range ( percentage) - hypoglycemia (mean daily percentage of hypo- glycemia less than 70 mg/dl) - hyperglycemia(mean daily percentage of hyper- glycemia above than 180mg/dl)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov